XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 15, 2023
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2022
Allocated share-based compensation expense   $ 78.0 $ 76.0  
Cost of revenue        
Allocated share-based compensation expense   5.2 5.4  
Research and Development        
Allocated share-based compensation expense [1]   55.4 52.9  
Research and Development | President        
Allocated share-based compensation expense $ (6.7)     $ 4.4
Sales and marketing        
Allocated share-based compensation expense   5.1 5.5  
General and administrative        
Allocated share-based compensation expense   $ 12.3 $ 12.2  
[1] On March 15, 2023, the Company's President resigned, resulting in the reversal of $6.7 million in stock-based compensation expense. Of the total amount reversed, $4.4 million related to expense recognized prior to January 1, 2023.